Investigation of doxorubicin tissue toxicity: Does Amifostine provide chemoprotection? An experimental study

Anticancer Research

Volumn 22, Issue 1 A, 2002, Pages 129-134

  Rigatos, Sotiris K ^a   Stathopoulos, George P ^a   Dontas, Ismene ^a   Perrea Kotsarelis, Despina ^a   Couris, Ephrosini ^a   Karayannacos, Panayotis E ^a   Deliconstantinos, George ^a  

^a NONE   (Greece)

Author keywords

Amifostine; Doxorubicin; Toxicity

Indexed keywords

AMIFOSTINE; CHOLESTEROL; DOXORUBICIN; GLUTATHIONE PEROXIDASE; OXYGEN RADICAL; SCAVENGER; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CARDIOTOXICITY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; FEMALE; HEART PROTECTION; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

AMIFOSTINE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARDIOMYOPATHIES; CHOLESTEROL; DOXORUBICIN; DRUG INTERACTIONS; FEMALE; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; TRIGLYCERIDES;

EID: 0036244324     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Adriamycin associated cardiotoxicity. Research on precaution with coenzyme Q
2. Doxorubicin cardiomyopathy. Evaluation by phonocardiography endomyocardic biopsy and cardiac catheterization
3. Management with chemotherapy only of stage I and II malignant lymphoma of aggressive histologic types
4. Salvage chemotherapy with ABVD in MOPP resistant Hodgkin's disease
5. Results of randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia
6. Cancer of the breast
7. 5-Fluorouracil, mitomycin-C and adriamycin (FAM): A new combination chemotherapy program for advanced gastric carcinoma
8. Reduction by ICRF-187 of acute daunorubicin toxicity in Syrian Golden Hamsters
9. Reducing the cardiotoxicity of the anthracyclines
10. Doxorubicin cardiotoxicity and serum lipid increase is prevented by dexrazoxane (ICRF-187)
11. WR-2721: A chemotherapy and radiation protective agent
12. Phase I trials of WR-2721 and cisplatinum
13. Inhibition of adriamycin cardiotoxicity by 5-fluorouracil: A potential free oxygen radical scavenger
14. Evaluation of anthracycline cardiotoxicity: Predictive ability and function correlation of endomyocardial biopsy
15. Enhancement of reactive oxygen-dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycin
16. Thy enzymatic defences of the mouse heart against reactive metabolites